Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIAID

Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus

  • Read more about Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus
Belgium
11000126.0
Filed on 2003-01-09

REDUCING CXCR4 EXPRESSION AND/OR FUNCTION TO ENHANCE ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS

  • Read more about REDUCING CXCR4 EXPRESSION AND/OR FUNCTION TO ENHANCE ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS
Patent Cooperation Treaty
PCT/US2015/040954
Filed on 2015-07-17

Attenuated Chlamydia Vaccine

  • Read more about Attenuated Chlamydia Vaccine
US Patent 10,258,682
Filed on 2015-07-16

STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

  • Read more about STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF
Patent Cooperation Treaty
PCT/US2015/032695
Filed on 2015-05-27

POLYMER ADJUVANT

  • Read more about POLYMER ADJUVANT
United Kingdom
1418004.6
Filed on 2014-10-10

Newly Discovered Bacterium In The Family Acetobacteraceae

  • Read more about Newly Discovered Bacterium In The Family Acetobacteraceae
US Application 14/717,911
Filed on 2015-05-20

Treatment or Prevention of an Intestinal Disease or Disorder

  • Read more about Treatment or Prevention of an Intestinal Disease or Disorder
Patent Cooperation Treaty
PCT/US2015/031200
Filed on 2015-05-15

Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses

  • Read more about Development of Mutations Useful for Attenuating Dengue Viruses and Chimeric Dengue Viruses
Australia
2015203575
Filed on 2015-06-26

Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus

  • Read more about Construction of West NIle Virus And Dengue Virus Chimeras For Use In A Live Virus Vaccine To Prevent Disease Caused by West Nile Virus
European Patent
15163537.2
Filed on 2003-01-09

Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines

  • Read more about Use Of Peptide-manganous Complexes To Protect Microorganisms And Cells From Radiation Damage During Creation Of Lethally Irradiated Vaccines
Brazil
1120120277405
Filed on 2012-11-01

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 291
  • Page 292
  • Page 293
  • Page 294
  • Page 295
  • Page 296
  • Page 297
  • Page 298
  • Page 299
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIAID
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health